drugset / Trial / NCT06845540

Oral Metformin for Treating Melasma in Latin American Women

NCT06845540

Phase 1/2 Recruiting 30 enrolled University of Puerto Rico
NaSingle-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to learn if metformin can treat melasma in Latin American women. The main question it aims to answer is: \- Can metformin help reduce the dark patches of melasma? Researchers will test two different doses of metformin (500 mg and 1000 mg) to see if either one helps improve melasma. Participants will: * Take a metformin pill every day for three months. * Go to the clinic twice: once at the beginning and once at the end of the study. * Get a phone call from the researchers to check how they're doing and ask about any changes or side effects.

Timeline

Start
2025-02-20
Primary completion
2025-05-22
Completion
2025-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 500 mg Oral